MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

GlaxoSmithKline plc Company Profile (LON:GSK)

Consensus Ratings for GlaxoSmithKline plc (LON:GSK) (?)
Ratings Breakdown: 2 Sell Rating(s), 18 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.15)
Consensus Price Target: GBX 1,535.52

Analysts' Ratings History for GlaxoSmithKline plc (LON:GSK)
Show:
DateFirmActionRatingPrice TargetActions
7/1/2016Citigroup Inc.Reiterated RatingBuyGBX 1,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016BNP ParibasReiterated RatingNeutralGBX 1,430View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Deutsche Bank AGReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Credit Suisse Group AGReiterated RatingNeutralGBX 1,440View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Beaufort SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Shore CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/14/2016Jefferies GroupReiterated RatingHoldGBX 1,500View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2016Goldman Sachs Group Inc.Set Price TargetBuyGBX 1,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,470View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Morgan StanleySet Price TargetNeutralGBX 1,500View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Barclays PLCBoost Price TargetOverweightGBX 1,650 -> GBX 1,670View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Independent Research GmbHSet Price TargetNeutralGBX 1,550View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016HSBCBoost Price TargetBuyGBX 1,800 -> GBX 1,865View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Societe GeneraleReiterated RatingSellGBX 1,300View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Sanford C. BernsteinSet Price TargetNeutralGBX 1,496View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016Liberum CapitalReiterated RatingHoldGBX 1,350View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016AlphaValueReiterated RatingAddGBX 1,536View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2016Baader BankReiterated RatingHoldGBX 1,530View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2016Berenberg BankBoost Price TargetHoldGBX 1,590 -> GBX 1,600View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016Leerink SwannReiterated RatingMarket PerformGBX 1,565View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Bryan, Garnier & CoUpgradeBuyGBX 1,635View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016NatixisReiterated RatingNeutralGBX 1,470View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015JP Morgan CazenoveReiterated RatingNeutralGBX 1,370View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Oddo SecuritiesReiterated RatingReduceGBX 1,360View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/5/2015Kepler Capital MarketsReiterated RatingHoldGBX 1,540View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/7/2015Bank of America Corp.UpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Cenkos Securities LtdReiterated RatingBuyGBX 1,643View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Charles StanleyReiterated RatingaccumulateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2014KillikReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for GlaxoSmithKline plc (LON:GSK)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for GlaxoSmithKline plc (LON:GSK)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for GlaxoSmithKline plc (LON:GSK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
4/27/2016GBX 191.28%5/12/20165/12/20167/14/2016Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015GBX 191.34%11/12/201511/12/20151/14/2016Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015GBX 201.34%2/18/20162/18/20164/14/2016Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015GBX 191.38%8/13/20158/13/201510/1/2015Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015GBX 191.25%5/14/20155/14/20157/9/2015Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015GBX 231.56%2/19/20152/19/20154/9/2015Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014GBX 191.37%11/6/201411/6/20141/8/2015Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014GBX 191.28%8/6/20148/6/201410/2/2014Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014GBX 191.17%5/14/20145/14/20147/10/2014Tweet This Announcement  Share This Announcement on StockTwits
2/5/2014GBX 231.36%2/19/20142/19/20144/10/2014Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013GBX 191.15%11/13/201311/13/20131/9/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for GlaxoSmithKline plc (LON:GSK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/9/2016Dingemans,SimonInsiderBuy9GBX 1,441£129.69Tweet This Trade  Share This Trade on StockTwits
5/20/2016Slaoui,MoncefInsiderBuy14GBX 2,100£294Tweet This Trade  Share This Trade on StockTwits
5/12/2016Slaoui,MoncefInsiderBuy24GBX 2,103£504.72Tweet This Trade  Share This Trade on StockTwits
5/11/2016Witty,Sir Andrew PInsiderBuy8GBX 1,476£118.08Tweet This Trade  Share This Trade on StockTwits
4/28/2016Witty,Sir Andrew PInsiderSell10,000GBX 1,475£147,500Tweet This Trade  Share This Trade on StockTwits
4/14/2016Slaoui,MoncefInsiderBuy495GBX 2,156£10,672.20Tweet This Trade  Share This Trade on StockTwits
3/31/2016Anderson,Sir RoyInsiderBuy511GBX 1,405£7,179.55Tweet This Trade  Share This Trade on StockTwits
3/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,404£126.36Tweet This Trade  Share This Trade on StockTwits
2/15/2016Dingemans,SimonInsiderSell39,987GBX 1,406£562,217.22Tweet This Trade  Share This Trade on StockTwits
2/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21Tweet This Trade  Share This Trade on StockTwits
1/28/2016Dingemans,SimonInsiderBuy684GBX 1,381£9,446.04Tweet This Trade  Share This Trade on StockTwits
1/14/2016Witty,Sir Andrew PInsiderBuy43GBX 1,369£588.67Tweet This Trade  Share This Trade on StockTwits
1/12/2016Dingemans,SimonInsiderBuy9GBX 1,359£122.31Tweet This Trade  Share This Trade on StockTwits
12/9/2015Dingemans,SimonInsiderBuy9GBX 1,325£119.25Tweet This Trade  Share This Trade on StockTwits
11/10/2015Dingemans,SimonInsiderBuy9GBX 1,366£122.94Tweet This Trade  Share This Trade on StockTwits
10/12/2015Dingemans,SimonInsiderBuy10GBX 1,307£130.70Tweet This Trade  Share This Trade on StockTwits
10/1/2015Rohner,UrsInsiderBuy525GBX 1,251£6,567.75Tweet This Trade  Share This Trade on StockTwits
9/10/2015Witty,Sir Andrew PInsiderBuy10GBX 1,318£131.80Tweet This Trade  Share This Trade on StockTwits
8/12/2015Dingemans,SimonInsiderBuy8GBX 1,443£115.44Tweet This Trade  Share This Trade on StockTwits
7/10/2015Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21Tweet This Trade  Share This Trade on StockTwits
7/1/2015Wijers,HansInsiderBuy534GBX 13.45GBX 7,182.30Tweet This Trade  Share This Trade on StockTwits
3/31/2015Sir Christopher GentInsiderBuy3,991GBX 1,566£62,499.06Tweet This Trade  Share This Trade on StockTwits
3/9/2015Moncef SlaouiInsiderSell22,274GBX 1,544£343,910.56Tweet This Trade  Share This Trade on StockTwits
2/18/2015Moncef SlaouiInsiderSell1,580GBX 1,553£24,537.40Tweet This Trade  Share This Trade on StockTwits
2/13/2015Simon DingemansInsiderSell12,605GBX 1,543.12£194,510.28Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for GlaxoSmithKline plc (LON:GSK)
DateHeadline
06/30/16 04:35 PMGlaxoSmithKline starts Phase I antibody trial
06/29/16 04:15 PMGlaxoSmithKline plc (ADR) (NYSE:GSK)'s Company Shares Decreased 2.45% After High Volatility - Engelwood Daily
06/29/16 04:15 PMTwo Buzzers within Analysts Radar: Rock Creek Pharmaceuticals, Inc. (RCPI) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates
06/29/16 04:15 PMHC Stocks in Top Row: GlaxoSmithKline plc (ADR) (NYSE:GSK), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release)
06/27/16 08:45 AMShare Update and Earnings Review for GlaxoSmithKline PLC (NYSE:GSK) - Press Telegraph
06/27/16 08:45 AMAnalyst Rating Trends to Observe: Abbott Laboratories (NYSE:ABT) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates
06/27/16 08:45 AMNext Weeks Broker Price Targets For GlaxoSmithKline PLC (NYSE:GSK) - Fiscal Standard
06/27/16 08:45 AMShares of GlaxoSmithKline PLC (NYSE:GSK) Sees Large Inflow of Net Money Flow - Trade Calls
06/25/16 04:04 PMDr. Reddy’s Laboratories, GSK end tie-up in emerging markets
06/24/16 03:00 PMUW researchers compete for $1M prize from GlaxoSmithKline with device for bladder control, sexual function -
06/24/16 11:12 AMCitigroup disclosed (LON:GSK) GlaxoSmithKline PLC, maintaining its stock price target to GBX0 today - Breaking Finance News
06/24/16 10:56 AMFTSE closes down 3.2 percent, banks and housebuilders slump - [Reuters] - The FTSE 100 index initially dived more than 8 percent at the open, and was poised to post its sharpest one-day drop since the aftermath of the Lehman Brothers collapse. The FTSE 100 clawed back ground to finish 3.2 percent lower at 6,138.69 points.
06/23/16 03:32 PMNSE index rises 3.31%, as GlaxoSmithkline, Champion, Transcorp add weight
06/23/16 03:32 PMGSK August 5th Options Begin Trading
06/23/16 01:47 PMGlaxoSmithKline Has No Cure for Sideways Action -
06/23/16 09:57 AMGAVI alliance offers matched funds for GSK malaria vaccine pilot - [Reuters] - The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline's first-generation malaria vaccine, but only if other organisations promise to match that commitment. Evidence so far on the shot, developed by the British drugmaker with financial backing from the Bill & Melinda Gates Foundation, "suggests a malaria vaccine could have a significant impact in reducing malaria mortality in Africa", but more research is needed, GAVI said. Speaking to Reuters after a board meeting in Geneva, Seth Berkley, GAVI's chief executive, said the alliance was ready "to play its part" in backing the first phase pilot studies if other funders also came forward.
06/22/16 04:25 PMGlaxoSmithKline PLC (NYSE:GSK) Analyst Rating Consensus - Trade Calls
06/22/16 03:00 AMGlaxoSmithKline plc vs Smith & Nephew plc: which is the FTSE 100’s best medical marvel? -
06/20/16 04:09 PMGlaxo's triple combo smoker's cough treatment passes phase III
06/20/16 10:33 AMGlaxoSmithKline PLC (LON:GSK) price target maintained to GBX0 as recorded today by Shore Capital - Breaking Finance News
06/17/16 04:12 PMHC Stocks in Hub: GlaxoSmithKline plc (ADR) (NYSE:GSK), Exelixis, Inc. (NASDAQ:EXEL) - share market updates (press release)
06/15/16 01:23 PMPerrigo Deal Rumors Are Just Smoke -
06/15/16 11:17 AMWhat Exactly Are Bio-Electronics? -
06/15/16 08:57 AMIPM Great HR Debate 2016: GlaxoSmithkline meets PABC at finals on 21 June
06/14/16 04:11 PMNSE ASI drops 0.26% as GSK, Unity Bank, FCMB lead losers
06/14/16 04:11 PMGlaxoSmithKline Vaccines Unit Chairman to Retire Next Year
06/14/16 04:11 PMOversold Conditions For GlaxoSmithKline (GSK)
06/14/16 01:50 PM[$$] GlaxoSmithKline Vaccines Unit Chairman to Retire Next Year -
06/13/16 04:01 PMMost Recent Analysts Ratings Report: GlaxoSmithKline PLC (NYSE:GSK) , UnitedHealth Group Incorporated (NYSE ... - Street Updates
06/13/16 04:01 PMEarnings Overview: Intel Corporation (NASDAQ:INTC), GlaxoSmithKline plc (NYSE:GSK) - Beacon Chronicle
06/09/16 04:01 AMOnly One Big Drugmaker Is Working on a Nanobot Cure -
06/09/16 03:49 AMDividend delight: Is Auto Trader Group plc a BETTER income bet than GlaxoSmithKline plc or Vodafone Group plc? -
06/08/16 04:27 AMInternational Business Machines Corp. (NYSE:IBM) Wants To Sell AI GlaxoSmithKline PLC (NYSE:GSK) - Market Exclusive
06/08/16 03:38 AMNew Phase III data shows greater treatment response with GSK’s Benlysta® (belimumab) vs placebo in patients with highly active SLE - [at noodls] - Issued: London GSK today announced data at the Annual European Congress of Rheumatology (EULAR 2016) showing that patients with highly active systemic lupus erythematosus (SLE) experienced a significantly ...
06/08/16 02:14 AM4 powerful reasons to get into British markets now, before the Brexit vote - [at MarketWatch] - As the Brexit referendum nears, investors are getting needlessly skittish, writes Matthew Lynn, who lists four powerful reasons to buy British assets now ahead of the vote.
06/07/16 12:18 PMGlaxoSmithKline Plc – Value Analysis (LONDON:GSK) : June 7, 2016 -
06/07/16 02:20 AM3 top long-term ISA holdings: GlaxoSmithKline plc, Unilever plc and City of London Investment Trust plc -
06/04/16 04:02 AMGlaxoSmithKline plc (GSK) Stock Rating Reaffirmed by Beaufort Securities - Let Me Know About This
06/03/16 11:01 PM[$$] Brexit Looms Over British Stocks -
06/03/16 04:37 AMNotable Runners: Array Biopharma Inc (NASDAQ:ARRY), GlaxoSmithKline plc (ADR)(NYSE:GSK) - NYSE Journal (press release) - Notable Runners: Array Biopharma Inc (NASDAQ:ARRY), GlaxoSmithKline plc (ADR)(NYSE:GSK)NYSE Journal (press release)GlaxoSmithKline plc (ADR)(NYSE:GSK), jumped 0.59% and closed at $42.41 in the last trading session. The last trading range of the stock ranges between $41.94 and $42.43. The company's Market capitalization is $102.19 Billion with the total Outstanding ...and more »
06/03/16 04:37 AMBeaufort Securities Restated Buy Rating For GlaxoSmithKline PLC (LON:GSK) - HNN - HNNBeaufort Securities Restated Buy Rating For GlaxoSmithKline PLC (LON:GSK)HNNToday, Beaufort Securities kept their Buy rating on GlaxoSmithKline PLC (LON:GSK)'s stock in a report issued to clients. Out of 24 analysts covering GlaxoSmithKline PLC (LON:GSK), 9 rate it a “Buy”, 2 “Sell”, while 17 “Hold”. This means 32% are positive.New Analyst Ratings For GlaxoSmithKline (LON:GSK)Share Trading Newsall 139 news articles »
06/03/16 03:40 AMWhy GlaxoSmithKline plc and BTG plc are the perfect prescription for growth and income! -
06/03/16 03:21 AMBotswana gets GSK's modern HIV drug in largest ever Africa tender -
06/01/16 04:05 AMAttention Seekers of Healthcare Sector: GlaxoSmithKline plc (ADR) (NYSE:GSK), Baxter International Inc (NYSE:BAX ... - The Point Review - The Point ReviewAttention Seekers of Healthcare Sector: GlaxoSmithKline plc (ADR) (NYSE:GSK), Baxter International Inc (NYSE:BAX ...The Point ReviewShares of GlaxoSmithKline plc (ADR) (NYSE:GSK) fell -0.80% to $42.42 at 12:20 PM EDT. The stock attained the volume of 1.47 Million shares recently versus average trading volume of 2.87 Million shares. If we take a look on its volatility, 0.65 percent ...and more »
05/31/16 08:37 AMShare Rating Focus on GlaxoSmithKline PLC (NYSE:GSK) - HNN - Share Rating Focus on GlaxoSmithKline PLC (NYSE:GSK)HNNPresently, Wall Street analysts have given a consensus stock rating of 2.71 on shares of GlaxoSmithKline PLC (NYSE:GSK). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus number is ...and more »
05/31/16 08:37 AMStocks Recommendation Update: CVS Health Corporation (NYSE:CVS) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates - Stocks Recommendation Update: CVS Health Corporation (NYSE:CVS) , GlaxoSmithKline PLC (NYSE:GSK)Street UpdatesGlaxoSmithKline PLC (NYSE:GSK) after beginning at $42.72, closed at $42.75 by cutting down -0.79% in recent trading session. Most recent session's volume of 2.04 million shares lower than its average volume of 3.23 million shares. The company has ...and more »
05/29/16 07:49 PMGlaxoSmithKline PLC (NYSE:GSK) Quarterly EPS From Continuing Operations Stands At $0.2081 - Investor Newswire - GlaxoSmithKline PLC (NYSE:GSK) Quarterly EPS From Continuing Operations Stands At $0.2081Investor NewswireGlaxoSmithKline PLC (NYSE:GSK) diluted EPS from parent firm came at $5.2689 for the year ended 2016-03-31. For the quarter ended 2016-03-31 it came at $5.2689. GlaxoSmithKline PLC (NYSE:GSK) posted net basic EPS of $5.33 for the year ended ...Glaxosmithkline Plc (NYSE:GSK) Shorted Shares Increased By 21.13%The PostCurrent Price Targets For GlaxoSmithKline PLC (NYSE:GSK)Risers & FallersWere Analysts Bullish GlaxoSmithKline plc (ADR) (NYSE:GSK) This Week?Franklin Independentall 5 news articles »
05/27/16 02:52 PMHealthcare Stock's Latest Update : Ionis Pharmaceuticals Inc (NASDAQ:IONS) , GlaxoSmithKline PLC (NYSE:GSK) - Is stories - BenzingaHealthcare Stock's Latest Update : Ionis Pharmaceuticals Inc (NASDAQ:IONS) , GlaxoSmithKline PLC (NYSE:GSK)Is storiesIn most recently trading session on 5/26/2016, GlaxoSmithKline PLC (NYSE:GSK) dropped -0.07% while traded on 1.85 million shares versus it's an average volume of 3.23 million shares. The company recorded the last trade with the price of $43.09.GlaxoSmithKline plc (NYSE:GSK) Decides Against Beginning A Phase-Three Study For Ionis-TTRStreet Wise Report (press release) (blog)Cowen Downgrades Ionis After Thrombocytopenia IssuesBenzingaIonis Down, Glaxo Dumps IONIS-TTRRx Phase III Study PlansNasdaqYahoo News -Reuters -Bidness ETCall 74 news articles »
05/27/16 02:52 PMWelch & Forbes LLC Increased Glaxosmithkline Plc (NYSE:GSK) by $6.90 Million as Shares Rose - CCH Daily News - Welch & Forbes LLC Increased Glaxosmithkline Plc (NYSE:GSK) by $6.90 Million as Shares RoseCCH Daily NewsWelch & Forbes Llc increased its stake in Glaxosmithkline Plc (NYSE:GSK) by 34.66% based on its latest 2016Q1 regulatory filing with the SEC. Welch & Forbes Llc bought 172,600 shares as the company's stock rose 0.25% with the market. The institutional ...and more »
05/27/16 10:37 AMStrimvelisTM receives European marketing authorisation to treat very rare disease, ADA-SCID - [at noodls] - Issued: London GSK, Fondazione Telethon and Ospedale San Raffaele gain approval to provide life-saving gene therapy to patients. ... This is an abstract of the original noodl. To continue reading this ...
About GlaxoSmithKline plc

GlaxoSmithKline plc logoGlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company's segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals business develops and makes medicines to treat a range of acute and chronic diseases. The Vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across the world. The Consumer Healthcare business develops and markets products in various categories, such as Wellness, Oral health, Nutrition and Skin health. The Pharmaceuticals Research and Development (R&D) focuses on the discovery and development in various areas of research, which include human immunodeficiency virus (HIV) and infectious diseases, oncology, immuno-inflammation, respiratory and rare diseases.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: GSK
  • CUSIP:
Key Metrics:
  • Previous Close: $21.11
  • 50 Day Moving Average: $1452.01
  • 200 Day Moving Average: $1418.75
  • P/E Ratio: 126.98
  • P/E Growth: 2.66
  • Market Cap: $77.73B
  • Current Quarter EPS Consensus Estimate: $89.43 EPS
Additional Links:

            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha